Source: Liver International. Conference titles: Bienal Scientific Meeting of the International Association for the Study of the Liver. Unidade: FMRP
Assunto: HEPATITE C (TRATAMENTO)
ABNT
PARISE, E. R. et al. Peginterferon alpha-2a plus ribavirin in the retreatment of chronic hepatitis C patients, non-responders and relapsers to previous conventional interferon plus ribavirin therapy. Liver International. Copenhagen: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 19 set. 2024. , 2004APA
Parise, E. R., Meirelles, A., Martinelli, A. de L. C., Lacet, C., Crespo, D., Correa, E., et al. (2004). Peginterferon alpha-2a plus ribavirin in the retreatment of chronic hepatitis C patients, non-responders and relapsers to previous conventional interferon plus ribavirin therapy. Liver International. Copenhagen: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.NLM
Parise ER, Meirelles A, Martinelli A de LC, Lacet C, Crespo D, Correa E, Cotrim H, Sette Júnior H, Cheinquer H, Gallizi J, Fonseca J, Pessoa M, Lima L, Pereira L, Paraná R, Silva MR, Teixeira R, Spinelli V, Amorim W, Oliveira A, Gomes A, Villanova M, Silva R, Coelho-Borges S, Tatsch F. Peginterferon alpha-2a plus ribavirin in the retreatment of chronic hepatitis C patients, non-responders and relapsers to previous conventional interferon plus ribavirin therapy. Liver International. 2004 ; 24 16.[citado 2024 set. 19 ]Vancouver
Parise ER, Meirelles A, Martinelli A de LC, Lacet C, Crespo D, Correa E, Cotrim H, Sette Júnior H, Cheinquer H, Gallizi J, Fonseca J, Pessoa M, Lima L, Pereira L, Paraná R, Silva MR, Teixeira R, Spinelli V, Amorim W, Oliveira A, Gomes A, Villanova M, Silva R, Coelho-Borges S, Tatsch F. Peginterferon alpha-2a plus ribavirin in the retreatment of chronic hepatitis C patients, non-responders and relapsers to previous conventional interferon plus ribavirin therapy. Liver International. 2004 ; 24 16.[citado 2024 set. 19 ]